Role of soluble interleukin-2 receptor (sIL-2R) as a predictor for severe dengue infection

被引:0
|
作者
Singh, Arkit Deep [1 ]
Saroch, Atul [1 ]
Pannu, Ashok Kumar [1 ]
Yadav, Ashok Kumar [2 ]
Sharda, Saurabh C. [1 ]
Bhatia, Mandeep [1 ]
Kamboj, Kajal [2 ]
机构
[1] PGIMER Chandigarh, Nehru Hosp, Dept Internal Med, Room 11,4th Floor F Block, Chandigarh, India
[2] PGIMER Chandigarh, Dept Expt Med & Biotechnol, Chandigarh, India
来源
SCIENTIFIC REPORTS | 2025年 / 15卷 / 01期
关键词
ACTIVATION; DIAGNOSIS; RECEPTOR; CHILDREN; DISEASE; SCORE; SERA;
D O I
10.1038/s41598-025-91274-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Annually, around half a million people with severe dengue require hospitalization, all over the globe, with around 12,500 (2.5%) succumbing to the illness. In this prospective observational study, we recruited 74 patients with dengue infection, 28 had severe dengue and 46 had dengue with warning signs. sIL-2R levels were significantly raised in the severe dengue group, compared to the warning signs group. Using an ROC curve (receive operator characteristic), at a cutoff of 5.379 ng/ml, it predicted the severe dengue classification with a p-value of < 0.001. As a marker for predicting hemophagocytic lymphohistiocytosis (HLH), the ROC curve revealed a cutoff of >= 5.379 ng/ml for sIL-2R levels with the AUROC being 0.83, suggesting a strong diagnostic performance(p-value < 0.001). sIL-2R levels can be used for predicting severe dengue classification with moderate sensitivity and specificity. Secondary HLH is an under-reported entity in dengue infection and early surveillance with the help of sIL-2R may be helpful in-patient care management.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Soluble interleukin-2 receptor (sIL-2R) profiles in kidney and liver transplant patients receiving basiliximab (SIMULECT)
    Kovarik, JM
    Gerbeau, C
    Legay, F
    Nashan, B
    Hall, M
    TRANSPLANTATION, 1999, 67 (07) : S196 - S196
  • [22] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) ASSAY IN CERVICAL AND ENDOMETRIAL CANCER - PRELIMINARY DATA
    FERDEGHINI, M
    GADDUCCI, A
    PRONTERA, C
    MARRAI, R
    MALAGNINO, G
    ANNICCHIARICO, C
    FIORETTI, P
    BIANCHI, R
    ANTICANCER RESEARCH, 1993, 13 (03) : 709 - 714
  • [23] SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) EXCRETION IN NORMAL PROTEINURIC AND IDIOPATHIC NEPHROTIC SYNDROME (INS) PATIENTS
    BOCK, GH
    ONGKINGCO, JR
    PATTERSON, LT
    RULEY, J
    NELSON, DL
    PEDIATRIC RESEARCH, 1991, 29 (04) : A339 - A339
  • [24] SERUM-SOLUBLE INTERLEUKIN-2 (IL-2) RECEPTOR (SIL-2R) IN DIFFERENTIATED THYROID-CARCINOMA
    MARIOTTI, S
    BARBESINO, G
    CATUREGLI, P
    MARINO, M
    MANETTI, L
    FUGAZZOLA, L
    PACINI, F
    PINCHERA, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (11) : 861 - 867
  • [25] Usefulness of Measurement of Soluble Interleukin-2 Receptor (sIL-2R) and Interleukin 6 to Monitor Efficacy of Specific Immunotherapy in Eosinophilic Esophagitis
    Armentia, Alicia
    Rodriguez, Angel San Miguel
    Martin-Armentia, Blanca
    Martin-Armentia, Sara
    Gonzalez-Sagrado, Manuel
    Hernandez, Angel San Miguel
    Conde, Rosa
    Lozano, Maria del Carmen
    Peinado, Irene Iglesias
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2021, 10 (02): : 173 - 179
  • [26] INTERLEUKIN-8(IL-8) AND THE SOLUBLE INTERLEUKIN-2 RECEPTOR (SIL-2R) ARE ELEVATED IN EXUDATIVE PLEURAL EFFUSIONS
    HEARTHHOLMES, M
    PAULSON, WD
    STOGNER, SW
    CAMPBELL, GD
    WOLF, RE
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S176 - S176
  • [27] Circadian rhythm of soluble interleukin-2 receptor (sIL-2R) and interleukin-6 (IL-6) in healthy individuals
    Undar, L
    Karadogan, I
    Altunbas, H
    Akca, S
    Ertugrul, C
    Ozturk, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1119 - 1119
  • [28] The role of soluble interleukin-2 (SIL-2R) receptors as a tumor marker in patients with advanced colorectal cancer (ACC)
    Pavlidis, N
    Bairaktari, E
    Nicolaides, C
    KalefEzra, J
    Athanassiadis, A
    Seferiadis, C
    Fountzilas, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1271 - 1271
  • [29] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    S Viviani
    E Camerini
    V Bonfante
    A Santoro
    M Balzarotti
    M Fornier
    L Devizzi
    P Verderio
    P Valagussa
    G Bonadonna
    British Journal of Cancer, 1998, 77 : 992 - 997
  • [30] Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications
    Viviani, S
    Camerini, E
    Bonfante, V
    Santoro, A
    Balzarotti, M
    Fornier, M
    Devizzi, L
    Verderio, P
    Valagussa, P
    Bonadonna, G
    BRITISH JOURNAL OF CANCER, 1998, 77 (06) : 992 - 997